Skip to content

Lariva Business

Lariva Blog

Menu
  • Privacy Policy
  • Tech Sharing
  • animate sharing
  • Science Sharing
  • Happening
Menu

Listen to this: “Hope in Dreams”, a new podcast from Nature Biotechnology

Posted on September 8, 2021 by William

Brady Haggett: Hello science talk audience. My name is Brady Huggett and I come from the journal Nature Biotechnology. We just launched a new podcast-an independent series-and the editors of Science Talk think you might be interested. This is a 10-part program that focuses on the history of antisense to the drug model, starting with an antisense pioneer who overcomes poverty, and a difficult childhood in order to achieve his own. Eventually, his company developed the first drug to treat spinal muscular atrophy, the main genetic killer of infants. We have made a trailer for the show, and now I want to play it for you. The podcast is titled “Hope in a Dream” and the first episode aired on September 8. Give you.

[Trailer]

Brady Haggett: Stan Crooke once told me something I will never forget. That was in 2015, when I interviewed him at the Hilton Hotel near Union Square in San Francisco. He attended a biotechnology conference in San Francisco and served as the CEO of a company he founded in 1989.

Stan grew up in extreme poverty in downtown Indianapolis in the 1940s and 1950s. An “ugly place”, as he said, when we talked, I asked him how he overcame that neighborhood and his tough upbringing, got himself to college, and then farther.

Stan Crook: Therefore, it is mainly despair and anger. It’s just that there is no hope, the whole idea of ​​ambition. What I mean is that poverty is not a loss of money-although of course it is pathetic. This is the loss of dreams, the lack of hope. That is poverty.

Brady Haggett: There is no real future.

Stan Crook: Besides. At least in my opinion, this is not even the ability to dream, you know?

Brady Haggett: This is the life story of Stan Crook. This is the story of the biotech company he founded, and the story of a powerful drug discovery technology called Antisense. Together, they solved a degenerative disease called spinal muscular atrophy, which has been taking the lives of children and traumatizing families since it was first discovered more than a century ago.

From Natural biotechnology, I am Brady Huggett, this is the hope of my dreams.

[theme music, snippets of dialogue]

“Can’t believe, can’t explain, can’t understand how this drug can fail”

“Like, one of the most amazing and dramatic moments in my life”

“So I thought, I have to sit here and watch my daughter slowly lose weight? Like, is this what I want to do?”

“The winner is Spinraza from Biogen and Ionis”

“When you have such a common vision with a group of people, and you have to say goodbye to half of them, it is a trauma.”

“This is what I have been thinking about, it is hope. SMA, especially infantile, is a terrible disease.”

“But if I’m telling the truth, it’s the truth”

Brady Haggett: Well, I spent more than two years reporting and writing, but I will not give up that minute. This is a fascinating story, and I think this story is also underestimated and underestimated. 10 chapters, one chapter every week, starting on September 8th. You can find it wherever you get a podcast: Apple, Google, Spotify, wherever it is, and subscribe there. Just look for the hope in your dreams. thanks for listening.

Recent Posts

  • F5 About 100 jobs will be cut due to the “current macroeconomic environment”
  • Neoriver decoration lights up Christmas
  • Naveen Jain’s microbiome and diagnostics startup Viome is raising more money
  • Cutting the wearable display in half is more difficult and easier than it looks
  • Oculus Studios acquired Camouflaj, a Seattle regional studio behind “Iron Man VR”
©2023 Lariva Business | Design: Newspaperly WordPress Theme